BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12672449)

  • 1. Are Huntington's and polyglutamine-based ataxias proteasome storage diseases?
    Goellner GM; Rechsteiner M
    Int J Biochem Cell Biol; 2003 May; 35(5):562-71. PubMed ID: 12672449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
    Bett JS; Goellner GM; Woodman B; Pratt G; Rechsteiner M; Bates GP
    Hum Mol Genet; 2006 Jan; 15(1):33-44. PubMed ID: 16311253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.
    Venkatraman P; Wetzel R; Tanaka M; Nukina N; Goldberg AL
    Mol Cell; 2004 Apr; 14(1):95-104. PubMed ID: 15068806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators.
    Realini C; Jensen CC; Zhang Z; Johnston SC; Knowlton JR; Hill CP; Rechsteiner M
    J Biol Chem; 1997 Oct; 272(41):25483-92. PubMed ID: 9325261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.
    Wyttenbach A; Carmichael J; Swartz J; Furlong RA; Narain Y; Rankin J; Rubinsztein DC
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2898-903. PubMed ID: 10717003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.
    Li J; Gao X; Ortega J; Nazif T; Joss L; Bogyo M; Steven AC; Rechsteiner M
    EMBO J; 2001 Jul; 20(13):3359-69. PubMed ID: 11432824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the possible inhibition of proteasome by direct interaction with ubiquitylated and aggregated huntingtin.
    Valera AG; Díaz-Hernández M; Hernández F; Lucas JJ
    Brain Res Bull; 2007 Apr; 72(2-3):121-3. PubMed ID: 17352935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions.
    Schmidt T; Lindenberg KS; Krebs A; Schöls L; Laccone F; Herms J; Rechsteiner M; Riess O; Landwehrmeyer GB
    Ann Neurol; 2002 Mar; 51(3):302-10. PubMed ID: 11891825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
    Michalik A; Van Broeckhoven C
    Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.
    Lafarga M; Berciano MT; Pena E; Mayo I; Castaño JG; Bohmann D; Rodrigues JP; Tavanez JP; Carmo-Fonseca M
    Mol Biol Cell; 2002 Aug; 13(8):2771-82. PubMed ID: 12181345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.
    Krobitsch S; Lindquist S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1589-94. PubMed ID: 10677504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligated proteins by closely linked mechanisms.
    Kanayama HO; Tamura T; Ugai S; Kagawa S; Tanahashi N; Yoshimura T; Tanaka K; Ichihara A
    Eur J Biochem; 1992 Jun; 206(2):567-78. PubMed ID: 1317798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.